Cost-effectiveness analysis of breast cancer control interventions in Peru

PloS One
Sten G ZelleRob Baltussen

Abstract

In Peru, a country with constrained health resources, breast cancer control is characterized by late stage treatment and poor survival. To support breast cancer control in Peru, this study aims to determine the cost-effectiveness of different breast cancer control interventions relevant for the Peruvian context. We performed a cost-effectiveness analysis (CEA) according to WHO-CHOICE guidelines, from a healthcare perspective. Different screening, early detection, palliative, and treatment interventions were evaluated using mathematical modeling. Effectiveness estimates were based on observational studies, modeling, and on information from Instituto Nacional de Enfermedades Neoplásicas (INEN). Resource utilizations and unit costs were based on estimates from INEN and observational studies. Cost-effectiveness estimates are in 2012 United States dollars (US$) per disability adjusted life year (DALY) averted. The current breast cancer program in Peru ($8,426 per DALY averted) could be improved through implementing triennial or biennial screening strategies. These strategies seem the most cost-effective in Peru, particularly when mobile mammography is applied (from $4,125 per DALY averted), or when both CBE screening and mammography...Continue Reading

References

Apr 17, 1998·The New England Journal of Medicine·J G ElmoreS W Fletcher
Jul 2, 1999·Cytopathology : Official Journal of the British Society for Clinical Cytology·J O ThomasA O Adesina
Apr 17, 2001·International Journal of Cancer. Journal International Du Cancer·K FlobbeJ M van Engelshoven
Jul 26, 2002·Seminars in Oncology·Gabriel N Hortobagyi
Apr 8, 2003·PharmacoEconomics·Davide Radice, Alberto Redaelli
Apr 26, 2003·The Breast Journal·Vladimir ZotovUNKNOWN PATH Breast Cancer Assistance Program
May 30, 2003·Cost Effectiveness and Resource Allocation : C/E·Jeremy A LauerChristopher JL Murray
Sep 11, 2003·Annals of Internal Medicine·Karla KerlikowskeDeborah Grady
Dec 23, 2003·Cost Effectiveness and Resource Allocation : C/E·Raymond HutubessyTessa Tan-Torres Edejer
Jan 26, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C BosettiC La Vecchia
Jan 26, 2005·British Journal of Cancer·S W Duffy, R Gabe
Nov 12, 2005·BMJ : British Medical Journal·Rob BaltussenChristopher Dye
Nov 12, 2005·BMJ : British Medical Journal·Taghreed AdamGary L Darmstadt
Feb 17, 2006·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Declan Walsh, Lisa Rybicki
Apr 17, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B C R DeviM Corbex
May 8, 2007·Journal of Pain and Symptom Management·Suresh K Kumar
Sep 7, 2007·Lancet·D ChisholmM Tomlinson
Apr 9, 2008·Acta Tropica·Grant Lewison, Divya Srivastava
Sep 11, 2008·Journal of the National Cancer Institute·Quirine Lamberts OkonkwoHarry J de Koning
Sep 11, 2008·Clinica Chimica Acta; International Journal of Clinical Chemistry·Shinichi UsuiMotoi Okamoto
Nov 13, 2008·Annals of Family Medicine·Margaret M EberlMartin C Mahoney
Jun 17, 2009·International Journal of Technology Assessment in Health Care·David Banta
Aug 22, 2009·International Journal of Cancer. Journal International Du Cancer·Indraneel MittraSurendra S Shastri
Nov 19, 2009·Annals of Internal Medicine·Jeanne S MandelblattUNKNOWN Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network
Mar 23, 2010·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Steven BroekxSteven Simoens
Feb 1, 2011·The Breast : Official Journal of the European Society of Mastology·B KooistraL Strobbe
Jun 15, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Sophie WhyteRon Akehurst
Jul 27, 2011·Pathology Research International·Mulazim Hussain Bukhari Shaharyar
Mar 6, 2012·BMJ : British Medical Journal·Joshua A SalomonEduardo González-Pier
Jul 18, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Sudarat NguansangiamKrittika Sosrisakorn
Jul 20, 2012·Tropical Medicine & International Health : TM & IH·Sten G ZelleRob Baltussen
Oct 9, 2013·Bulletin of the World Health Organization·Vivien Davis TsuBenjamin O Anderson

❮ Previous
Next ❯

Citations

Mar 13, 2020·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Shifali BansalChaitra Gopalappa
Dec 21, 2016·Bulletin of the World Health Organization·Melanie Y BertramSuzanne R Hill
Nov 16, 2016·Bulletin of the World Health Organization·Jane RobertsonNicola Magrini
Nov 3, 2017·Journal of Global Oncology·Rakesh Chopra, Gilberto Lopes
May 16, 2019·Health Care for Women International·Paul E NevinYamilé Molina
Dec 3, 2020·BMC Cancer·J Smith Torres-RomanCarlo La Vecchia
May 9, 2021·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Kyu-Tae HanSokbom Kang
Aug 17, 2021·International Journal of Cancer. Journal International Du Cancer·Brooke E WilsonMichael B Barton

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
dissection and
dissection
biopsy

Software Mentioned

RURAL
INEN
WHO
CHOICE
MINSA

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Revista Panamericana De Salud Pública = Pan American Journal of Public Health
Angel Martín Rosas AguirreMiguel Trelles de Belaunde
Revista española de salud pública
Haydeé Cárdenas QuintanaFelipe Mendoza Tasayco
Revista peruana de medicina experimental y salud pública
José Sánchez-Abanto
© 2021 Meta ULC. All rights reserved